The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 329:206-207 July 15, 1993 Number 3
NextNext

Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Rossaint, R.
To the Editor: Rossaint et al. (Feb. 11 issue)1 discussed the potential benefits of inhaled nitric oxide in the adult respiratory distress syndrome (ARDS). Their hypothesis is that inhalation of nitric oxide causes selective vasodilation of the pulmonary vascular bed in the ventilated lung regions, improving oxygenation and cardiac performance and reducing the accumulation of extravascular lung water. The study patients had a mild elevation of pulmonary-artery pressure that was of no apparent hemodynamic consequence, since their cardiac output was normal. Inhalation of nitric oxide reduced pulmonary-artery pressure slightly and did not change cardiac output. This confirms that its hemodynamic . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.